Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.36 |
| ▸ | TERT | O14746 | 1/20 | 0.35 |
| ▸ | ITGB3 | P05106 | 5/20 | 0.34 |
| ▸ | ITGA2B | P08514 | 5/20 | 0.34 |
| ▸ | CPB2 | Q96IY4 | 5/20 | 0.33 |
| ▸ | CPB1 | P15086 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.32 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.32 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.31 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.31 |
| ▸ | QRFPR | Q96P65 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5486869 | 1.00 | SLC15A2 (0.36) | SLC15A2TERTITGB3ITGA2BCPB2 | |
| SCHEMBL483989 | 0.99 | SLC15A2 (0.36) | SLC15A2TERTITGB3ITGA2BCPB2 | |
| SCHEMBL29591822 | 0.99 | SLC15A2 (0.36) | SLC15A2TERTITGB3ITGA2BCPB2 | |
| SCHEMBL5120251 | 0.99 | SLC15A2 (0.36) | SLC15A2TERTITGB3ITGA2BCPB2 | |
| SCHEMBL30629006 | 0.95 | SLC15A2 (0.39) | SLC15A2TERTITGB3ITGA2BCPB2 | |
| SCHEMBL20397438 | 0.92 | SLC15A2 (0.41) | SLC15A2ITGB3ITGA2BCPB2CPB1 | |
| SCHEMBL20397507 | 0.92 | SLC15A2 (0.41) | SLC15A2ITGB3ITGA2BCPB2CPB1 | |
| SCHEMBL29793353 | 0.91 | ITGB3 (0.34) | SLC15A2TERTITGB3ITGA2BCPB2 | |
| SCHEMBL1666820 | 0.91 | SLC15A2 (0.42) | SLC15A2ITGB3ITGA2BCPB2CPB1 | |
| SCHEMBL483799 | 0.91 | SLC15A2 (0.42) | SLC15A2ITGB3ITGA2BCPB2CPB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250295762-A1 | COMPOSITE BIOACTIVE COMPOSITIONS AND APPLICATIONS THEREOF | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2025-09-25 | — | — | US | claimed |
| WO-2025005781-A1 | ANTIMICROBIAL PEPTOID COMPRISING N-TERMINAL METAL COMPLEX | 광주과학기술원 | 2025-01-02 | — | — | WO | claimed |
| CN-118561955-A | Inhibitor of targeted carbonic anhydrase IX, molecular probe and application | 北京肿瘤医院(北京大学肿瘤医院) | 2024-08-30 | — | — | CN | claimed |
| US-9891187-B1 | Systems and methods for ion measurements | POLESTAR TECHNOLOGIES, INC. (US) | 2018-02-13 | — | — | US | claimed |
| EP-2793828-B1 | MOISTURIZING COMPOSITION COMPRISING AN AMINOPEPTIDE MIXTURE | UNILEVER PLC (GB) | 2016-08-24 | — | — | EP | claimed |
| US-20150291659-A1 | SOLOMONAMIDE ANALOGUE COMPOUNDS, PHARMACEUTICALS CONTAINING SOLOMONAMIDE ANALOGUE COMPOUNDS, AND PROCESSES FOR THE PREPARATION THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2015-10-15 | — | — | US | claimed |
| EP-2925771-A1 | A PROCESS FOR THE PREPARATION OF SOLOMONAMIDE ANALOGUES | Council of Scientific & Industrial Research (IN) | 2015-10-07 | — | — | EP | claimed |
| CN-104302271-A | Moisturizing composition comprising an aminopeptide mixture | UNILEVER NV | 2015-01-21 | — | — | CN | claimed |
| EP-2793828-A2 | MOISTURIZING COMPOSITION COMPRISING AN AMINOPEPTIDE MIXTURE | Unilever PLC, a company registered in England and Wales under company no. 41424 (GB) | 2014-10-29 | — | — | EP | claimed |
| WO-2014083578-A1 | A PROCESS FOR THE PREPARATION OF SOLOMONAMIDE ANALOGUES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESERACH AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860) (IN) | 2014-06-05 | — | — | WO | claimed |
| EP-1692569-A1 | PHOTOTHERMOGRAPHIC MATERIALS CONTAINING SENSITIZED SILVER HALIDE | EASTMAN KODAK COMPANY (US) | 2006-08-23 | — | — | EP | claimed |
| US-7026105-B2 | Photothermographic materials containing silver halide sensitized with combination of compounds | EASTMAN KODAK COMPANY (US) | 2006-04-11 | — | — | US | claimed |
| WO-2005062122-A1 | PHOTOTHERMOGRAPHIC MATERIALS CONTAINING SENSITIZED SILVER HALIDE | EASTMAN KODAK COMPANY (US) | 2005-07-07 | — | — | WO | claimed |
| US-20050123870-A1 | Photothermographic materials containing silver halide sensitized with combination of compounds | EASTMAN KODAK COMPANY | 2005-06-09 | — | — | US | claimed |
| US-6423481-B1 | PHOTOSENSITIVE SILVER HALIDE PARTICLES SENSITIZED WITH ORGANOSULFUR OR -TELLURIUM COMPOUND AND AN ORGANIC GOLD COMPLEX | EASTMAN KODAK COMPANY | 2002-07-23 | — | — | US | claimed |
| EP-0724154-A1 | Electrophoresis in low conductivity buffers | BIO-RAD LABORATORIES, INC. (US) | 1996-07-31 | — | — | EP | claimed |
| US-5464517-A | Injection of buffer, applying voltage and detection zones | BIO-RAD LABORATORIES (US) | 1995-11-07 | — | — | US | claimed |
| EP-0226304-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1991-08-28 | — | — | EP | claimed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | claimed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250295762-A1 | COMPOSITE BIOACTIVE COMPOSITIONS AND APPLICATIONS THEREOF | BMP2, BMP1, MATR3 | SLC15A2 3505/4885TERT 1717/4885ITGB3 537/4885 |
| US-20150291659-A1 | SOLOMONAMIDE ANALOGUE COMPOUNDS, PHARMACEUTICALS CONTAINING SOLOMONAMIDE ANALOGUE COMPOUNDS, AND PROCESSES FOR THE PREPARATION THEREOF | CNR2, SRM, CNR1 | SLC15A2 3402/4885TERT 4617/4885ITGB3 3528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.